ロード中...
Apatinib-treated advanced medullary thyroid carcinoma: a case report
Medullary thyroid carcinoma (MTC) is a rare malignancy originating from calcitonin-producing parafollicular C cells of the thyroid. Neither radiotherapy nor chemotherapy has demonstrated durable objective responses in patients with advanced MTC. Vandetanib and cabozantinib are the 2 tyrosine kinase...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783142/ https://ncbi.nlm.nih.gov/pubmed/29403290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S142598 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|